Rankings
▼
Calendar
PASG FY 2020 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$28M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$113M
Net Income
-$112M
EPS (Diluted)
$-57.80
Cash Flow
Operating Cash Flow
-$81M
Free Cash Flow
-$82M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$328M
Total Liabilities
$23M
Stockholders' Equity
$305M
Cash & Equivalents
$135M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$113M
-$37M
-203.6%
Net Income
-$112M
-$46M
-145.9%
← Q4 2019
All Quarters
Q1 2020 →